Alexandre Goyon

Alexandre Goyon

Auto-generated profile, based on publicly available information

Alexandre Goyon

Synthetic Molecule Analytical Chemistry, Genentech, 1 DNA Way, South San Francisco, California 94080, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2023 in Analytical Chemistry
Verified
Journal Article
Open access
AGAlexandre Goyon
Alexandre Goyon
STShijia Tang
Shijia Tang
SFSzabolcs Fekete
Szabolcs Fekete
DNDaniel Nguyen
Daniel Nguyen
KHKate Hofmann
Kate Hofmann
KZKelly Zhang
Kelly Zhang
Health authorities have highlighted the need to determine oligonucleotide aggregates. However, existing technologies have limitations that have prevented the reliable analysis of size variants for large nucleic acids and lipid nanoparticles (LNPs). In this work, nucleic acid and LNP aggregation was examined using prototype, low adsorption ultrawide pore size exclusion chromatography (SEC) columns. A preliminary study was conducted to determine the column's physicochemical properties. A large difference in aggregate content (17.8 vs 59.7 %) was found for a model messenger RNA (mRNA) produced by different manufacturers. We further investigated the nature of the aggregates via a heat treatment. Interestingly, thermal stress irreversibly decreased the amount of aggregates from 59.7 to 4.1% and increased the main peak area 3.3-fold. To the best of our knowledge, for the first time, plasmid DNA topological forms and multimers were separated by analytical SEC. The degradation trends were compared to the data obtained with an anion exchange chromatography method. Finally, unconjugated and fragment antigen-binding (Fab)-guided LNPs were analyzed and their elution times were plotted against their sizes as measured by DLS. Multi-angle light scattering (MALS) was coupled to SEC in order to gain further insights on large species eluting before the LNPs, which were later identified as self-associating LNPs. This study demonstrated the utility of ultrawide pore SEC columns in characterizing the size variants of large nucleic acid therapeutics and LNPs.

25 August 2023 in Journal of Chromatography A
Verified
Journal Article
Closed access
AGAlexandre Goyon
Alexandre Goyon
MBMolly S. Blevins
Molly S. Blevins
JNJosé G. Napolitano
José G. Napolitano
DNDaniel Nguyen
Daniel Nguyen
MGMeenakshi Goel
Meenakshi Goel
KZKelly Zhang
Kelly Zhang

Verified
Journal Article
Open access
PDF file
VDValentina D'Atri
Valentina D'Atri
HLHonorine Lardeux
Honorine Lardeux
AGAlexandre Goyon
Alexandre Goyon
MIMateusz Imiolek
Mateusz Imiolek
SFSzabolcs Fekete
Szabolcs Fekete
DGDavy Guillarme
Davy Guillarme
Biopharmaceutical products, in particular messenger ribonucleic acid (mRNA), have the potential to dramatically improve the quality of life for patients suffering from respiratory and infectious diseases, rare genetic disorders, and cancer. However, the quality and safety of such products are particularly critical for patients and require close scrutiny. Key product-related impurities, such as fragments and aggregates, among others, can significantly reduce the efficacy of mRNA therapies. In the present work, the possibilities offered by size exclusion chromatography (SEC) for the characterization of mRNA samples were explored using state-of-the-art ultra-wide pore columns with average pore diameters of 1000 and 2500 Å. Our investigation shows that a column with 1000 Å pores proved to be optimal for the analysis of mRNA products, whatever the size between 500 and 5000 nucleotides (nt). We also studied the influence of mobile phase composition and found that the addition of 10 mM magnesium chloride (MgCl2) can be beneficial in improving the resolution and recovery of large size variants for some mRNA samples. We demonstrate that caution should be exercised when increasing column length or decreasing the flow rate. While these adjustments slightly improve resolution, they also lead to an apparent increase in the amount of low-molecular-weight species (LMWS) and monomer peak tailing, which can be attributed to the prolonged residence time inside the column. Finally, our optimal SEC method has been successfully applied to a wide range of mRNA products, ranging from 1000 to 4500 nt in length, as well as mRNA from different suppliers and stressed/unstressed samples.

7 May 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
AGAlexandre Goyon
Alexandre Goyon
BSBrandon Scott
Brandon Scott
PYPeter Yehl
Peter Yehl
KZKelly Zhang
Kelly Zhang

21 August 2025 in Journal of Chromatography A
Verified
Journal Article
Closed access
AGAlexandre Goyon
Alexandre Goyon
DNDaniel Ngoc Nguyen
Daniel Ngoc Nguyen
KZKelly Zhang
Kelly Zhang

23 April 2026 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
XKXinqi Kang
Xinqi Kang
KZKelly Zhang
Kelly Zhang
AGAlexandre Goyon
Alexandre Goyon
WSWilliam Stephenson
William Stephenson
While nanopore direct RNA sequencing has substantially advanced transcriptomics, its detection of RNA modifications remains primarily focused on abundant biological base modifications. However, therapeutic RNAs employ a diverse catalog of modifications, including base, sugar, and backbone modifications, to enhance stability and pharmacological properties. To address this gap, we systematically evaluated a set of therapeutically relevant modifications [phosphorothioate (PS)], sugar [2′-O-methylation (2′OMe), 2′-Fluoro (2′F), locked nucleic acid (LNA), 2′-O-(2′-methoxyethyl) (2′MOE)], and base [N1-methylpseudouridine (m1Ψ), 5-methylcytidine (m5C), 5-methoxyuridine (5moU), and 5-iodocytidine (5iodoC)] using direct RNA nanopore sequencing. Modifications were systematically analyzed using basecall errors, raw current signals, and modification-aware basecalling models. Ribose modifications, m1Ψ, and 5moU induced significant error rate increases and noticeable current alterations, whereas 2′OMe and 2′MOE affected dwell time adjacent to the pore. In contrast, PS linkages produced only slight current alterations without increasing basecalling errors. We further evaluated modification-aware basecallers for 2′OMe and m5C. While these tools can distinguish modification types, they are limited by poor quantification accuracy and high local error rates, especially for 2′OMe. This study establishes a critical performance baseline, clarifying the current capability and limitations of nanopore technology for the analysis of therapeutically relevant RNA modifications.